Richard Ramko is a partner in Ernst & Young's South Florida practice, primarily serving publicly-held and emerging growth companies in the Health Sciences, Biotech and Technology industries.
Ramko has extensive experience serving large, publicly-held companies as well as newly formed start-ups and venture-backed enterprises. Richard has 15 years of experience, including 13 years in public accounting and 2 years in executive level financial positions in private industry and is a certified public accountant in Florida and Tennessee. Some of his current clients include Andrx Corporation, Nabi Biopharmaceuticals, Stiefel Laboratories and SFBC International.
What I like to do is provide a brief overview of the current state of the biotechnology industry. For the past 20 years, we prepared our biotechnology industry report Beyond Borders and this year's issue will be released at the annual bio meeting in Chicago next week. I can't give away any of the ...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
